1. Bachert, C., Bhattacharyya, N., Desrosiers, M., Khan, A. H. Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps. J. Asthma Allergy. 2021; 14: 127–134.
Google Scholar | Crossref | Medline2. Ryu, G., Kim, D. W. Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis. Current Opinion in Allergy and Clinical Immunology vol. 20 1–8 (2020).
Google Scholar | Crossref | Medline3. Stevens, W. W. et al. Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis. J. Allergy Clin. Immunol. Pract. 7, 2812–2820.e3 (2019).
Google Scholar4. Takabayashi, T. et al. A Phase II, Multicenter, Randomized, Placebo-Controlled Study of Benralizumab, a Humanized Anti-IL-5R Alpha Monoclonal Antibody, in Patients With Eosinophilic Chronic Rhinosinusitis. Am. J. Rhinol. Allergy 19458924211009428 (2021) doi:10.1177/19458924211009429.
Google Scholar | SAGE Journals5. Gan, W. et al. The influence of nasal microbiome diversity and inflammatory patterns on the prognosis of nasal polyps. Sci. Rep. 11, 6364 (2021).
Google Scholar6. Li, Y., Wang, W., Ying, S., Lan, F., Zhang, L. A Potential Role of Group 2 Innate Lymphoid Cells in Eosinophilic Chronic Rhinosinusitis With Nasal Polyps. Allergy. Asthma Immunol. Res. 13, 363–374 (2021).
Google Scholar | Crossref | Medline7. Persson, E. K. et al. Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. Science 364, (2019).
Google Scholar | Crossref | Medline8. Zhang, M., Yan, B., Wang, Y., Wang, C., Zhang, L. Charcot-Leyden Crystal Protein in Nasal Secretions of Patients with Nonallergic Rhinitis with Eosinophilia Syndrome. Int. Arch. Allergy Immunol. 1–9 (2020) doi:10.1159/000509252.
Google Scholar9. Chua, J. C., Douglass, J. A., Gillman, A., O’Hehir, R. E., Meeusen, E. N. Galectin-10, a potential biomarker of eosinophilic airway inflammation. PLoS One 7, (2012).
Google Scholar | Crossref10. Gelardi, M. et al. Nasal-sinus polyposis: Clinical-cytological grading and prognostic index of relapse. J. Biol. Regul. Homeost. Agents 23, 181–188 (2009).
Google Scholar | Medline11. Gelardi, M. et al. Non-surgical management of chronic rhinosinusitis with nasal polyps based on clinical-cytological grading: a precision medicine-based approach. Acta Otorhinolaryngol. Ital. 37, 38–45 (2017).
Google Scholar | Crossref | Medline12. Gelardi, M., Iannuzzi, L., Quaranta, N., Landi, M., Passalacqua, G. NASAL cytology: Practical aspects and clinical relevance. Clin. Exp. Allergy 46, 785–792 (2016).
Google Scholar | Crossref | Medline13. Heffler, E. et al. Nasal cytology: Methodology with application to clinical practice and research. Clinical and Experimental Allergy vol. 48 1092–1106 (2018).
Google Scholar | Crossref | Medline14. Gelardi, M., Russo, C., Fiorella, M. L., Fiorella, R., Ciprandi, G. Inflammatory cell types in nasal polyps. Cytopathology vol. 21 201–203 (2010).
Google Scholar | Crossref | Medline15. Gelardi, M., Landi, M., Ciprandi, G. Nasal cytology: a Precision Medicine tool in clinical practice. Clinical and Experimental Allergy vol. 48 96–97 (2018).
Google Scholar | Crossref | Medline16. Gallo, S. et al. Prognostic value of the sinonasal outcome test 22 (SNOT-22) in chronic rhinosinusitis. Acta Otorhinolaryngol. Ital. 40, 113–121 (2020).
Google Scholar | Crossref | Medline17. Stallone, G. et al. Semaphorin 3F expression is reduced in pregnancy complicated by preeclampsia. An observational clinical study. PLoS One 12, (2017).
Google Scholar | Crossref18. Netti, G. S. et al. LPS removal reduces CD80-mediated albuminuria in critically ill patients with gram-negative sepsis. Am. J. Physiol. - Ren. Physiol. 316, F723–F731 (2019).
Google Scholar | Crossref | Medline19. Netti, G. S. et al. PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma. Aging (Albany. NY). 12, 7585–7602 (2020).
Google Scholar | Crossref | Medline20. Dwyer, D. F. et al. Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation. Sci. Immunol. 6, (2021).
Google Scholar | Crossref | Medline21. Delemarre, T. et al. A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. 147, 179–188.e2 (2021).
Google Scholar | Crossref | Medline22. Lou, H. et al. Cellular phenotyping of chronic rhinosinusitis with nasal polyps. Rhinol. J. 54, 150–159 (2016).
Google Scholar | Crossref | Medline23. Liu, C. et al. Predictive Significance of Charcot–Leyden Crystals for Eosinophilic Chronic Rhinosinusitis With Nasal Polyps. Am. J. Rhinol. Allergy 33, 671–680 (2019).
Google Scholar | SAGE Journals24. Mulay, S. R. & Anders, H.-J. Crystallopathies. N. Engl. J. Med. 374, 2465–2476 (2016).
Google Scholar25. Wu, D., Yan, B., Wang, Y., Zhang, L., Wang, C. Predictive significance of charcot-leyden crystal protein in nasal secretions in recurrent chronic rhinosinusitis with nasal polyps. Int. Arch. Allergy Immunol. (2020) doi:10.1159/000510120.
Google Scholar | Crossref26. Wu, D., Yan, B., Wang, Y., Zhang, L., Wang, C. Predictive Significance of Charcot-Leyden Crystal Protein in Nasal Secretions in Recurrent Chronic Rhinosinusitis with Nasal Polyps. Int. Arch. Allergy Immunol. 182, 65–75 (2021).
Google Scholar | Crossref | Medline27. Su, J. et al. Galectin-10: a new structural type of prototype galectin dimer and effects on saccharide ligand binding. Glycobiology 28, 159–168 (2018).
Google Scholar | Crossref | Medline28. Gelardi, M. et al. Clinical-cytological-grading and phenotyping in patients with chronic rhinosinusitis with nasal polyps: The relevance in clinical practice. Monaldi Arch. Chest Dis. 90, 348–352 (2020).
Google Scholar | Crossref29. Peters, A. T. et al. Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps. J. Allergy Clin. Immunol. Pract. (2021) doi:10.1016/j.jaip.2021.01.031.
Google Scholar | Crossref30. Bachert, C. et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394, 1638–1650 (2019).
Google Scholar | Crossref | Medline31. Fokkens, W. J. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 58, 1–464 (2020).
Google Scholar | Crossref32. Yim, M. T., Orlandi, R. R., Oakley, G. M., Alt, J. A. The Sinonasal Outcome Test (SNOT-22) Is a Poor Diagnostic Tool for Chronic Rhinosinusitis. Ann. Otol. Rhinol. Laryngol. (2021) doi:10.1177/0003489421998213.
Google Scholar | SAGE Journals